Ayodeji Adegunsoye, MD, PhD
Enriched profileProfessor of Medicine, Section of Pulmonary and Critical Care Medicine · University of Chicago Medicine
Ayodeji Adegunsoye is Professor of Medicine, Section of Pulmonary and Critical Care Medicine at University of Chicago Medicine. OpenAlex indexes 264 publications with 6,068 citations (h-index 45); ClinicalTrials.gov lists 1 registered study with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Ayodeji Adegunsoye is Professor of Medicine, Section of Pulmonary and Critical Care Medicine at University of Chicago Medicine / University of Chicago Biological Sciences Division. The public record shows 264 publications with 6,068 citations (h-index 45), centered on Idiopathic Pulmonary Fibrosis. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 11 companies, 1 NIH-funded awards (2020–2024).
- Most recent indexed publication: 2026 · Histopathology
- Top research focus: Idiopathic Pulmonary Fibrosis
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 11 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 38 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis
Sponsor: University of Chicago
Industry payments
Updated 27 Aug 2026
11 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202563 payments$88,795openpaymentsdata.cms.gov ↗
- Inogen, Inc.Program year20258 payments
- Boehringer Ingelheim International GmbHProgram year20257 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
56.4%Pyridone38.6%Pirfenidone100%Part D<11 patientsKinase inhibitor17.8%Ofev100%Part D<11 patientsRespiratory
28.7%Corticosteroid14.9%Symbicort100%Part D<11 patientsbeta2-Adrenergic Agonist13.9%Albuterol Sulfate Hfa100%Part D<11 patientsMetabolism & gastrointestinal
14.9%Corticosteroid14.9%Prednisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
1 NIH research award on record, funded 2020–2024 per NIH RePORTER. The latest:
- Improving Pulmonary Fibrosis Classification with Genomics Informed Phenotypic Clusters
University of Chicago
FY2024$162,432K23HL146942 - Improving Pulmonary Fibrosis Classification with Genomics Informed Phenotypic Clusters
University of Chicago
FY2023$162,432K23HL146942 - Improving Pulmonary Fibrosis Classification with Genomics Informed Phenotypic Clusters
University of Chicago
FY2022$162,432K23HL146942
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Clinical applications of the 2025 ERS/ATS update of the international multidisciplinary classification of the interstitial pneumonias.
The European respiratory journal
Article2026 - Clinical utility of lung biopsy in fibrotic interstitial lung disease.
American journal of respiratory and critical care medicine
Review2026 - Rebuttal to "Bronchiolocentric interstitial pneumonia is a more accurate interstitial lung disease classification than hypersensitivity pneumonitis: con".
American journal of respiratory and critical care medicine
Article2026 - Bronchiolocentric interstitial pneumonia is a more accurate interstitial lung disease classification than hypersensitivity pneumonitis: pro.
American journal of respiratory and critical care medicine
Article2026
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/ayodeji-adegunsoye-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Ayodeji-Adegunsoye-2
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - LinkedIn
linkedin.com/in/ayodeji-adegunsoye-md-msc-phd-facp-fccp-a8a94120
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature them- YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
University of Ibadan College of Medicine (Nigeria)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmonaryfibrosis.org ↗ - MS
University of Chicago
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uchicagomedicine.org ↗ - PhD
University of Chicago
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →biologicalsciences.uchicago.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uchicagomedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uchicagomedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uchicagomedicine.org ↗
- Internal Medicine residency
Drexel University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmonaryfibrosis.org ↗
Editorial & leadership roles
journal and society appointments- Editorial Board
Annals of the American Thoracic Society
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →academic.oup.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →the-asci.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmonaryfibrosis.org ↗
Secondary affiliations
appointments beyond the home institution- Scientific Director
Interstitial Lung Disease Program, University of Chicago
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →med-faculty.bsd.uchicago.edu ↗ - Section of Pulmonary and Critical Care Medicine
Department of Medicine, University of Chicago
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →thelancet.com ↗
- Medscape InDiscussion podcast guest
"Idiopathic Pulmonary Fibrosis: Who Gets an Antifibrotic?"
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medscape.com ↗ - AMJ Podcast guest
Episode 3: "Shifting the Silence: The Evolving Landscape in Pulmonary Fibrosis" (with Toby Maher)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →emjreviews.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Wendy Stock, MD
University of Chicago Medicine
Gaurav Upadhyay, MD
University of Chicago Medicine
Michael Davidson, MD
University of Chicago Medicine